ARCHIVES

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 44 | November 13, 1992

Download PDF Visit The Full Archive

Related Articles

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Coalition Of Cooperative Groups Lists High Priority Trials In Breast Cancer.

October 17, 2008

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

April 23, 1982

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

September 23, 2005

Senate confirms Crawford as FDA commissioner.

July 22, 2005